Long Island & Queens Vitreo Retinal Consultants, P.C.

10/28/2025

A recent study found that pregnant women with type 1 diabetes are not at higher risk of developing sight-threatening diabetic retinopathy compared to nonpregnant women with the same condition. This is reassuring news for expecting mothers managing diabetes and eye health. Learn more: https://brnw.ch/21wX01Y

A study reveals similar risks of sight-threatening diabetic retinopathy in pregnant women with type 1 diabetes compared to nonpregnant controls.

10/23/2025

Belite Bio has completed a phase 3 clinical trial for tinlarebant, a potential first-ever treatment for Stargardt disease, a rare inherited form of vision loss. This oral medication aims to slow damage to the retina by reducing harmful vitamin A byproducts. Results are expected in late 2025. Learn more: https://brnw.ch/21wWS4e

Belite Bio completes its phase 3 trial for tinlarebant, a potential first treatment for Stargardt disease, with results expected in late 2025.

10/21/2025

Dr. David P**n is known for his thoughtful, clear, and expert approach to retinal care. Patients trust him not just for his skill, but for how well he explains every step!

10/17/2025

We are truly honored to be recognized by The American Society of Retina Specialists. VRCNY takes great pride in providing care rooted in compassion, ethics, and dedication to our patients every single day.

10/14/2025

A recent study found that individuals with age-related macular degeneration may have a higher risk of heart-related health issues, especially if they already have cardiovascular risk factors. Even early signs of AMD were linked to an increased likelihood of heart-related outcomes. Learn more: https://brnw.ch/21wWBNr

The presence of AMD predicted an increased risk of all-cause and CVD mortality in patients with a high risk of CVD, even in the early stages of AMD.

10/09/2025

Beacon Therapeutics has announced encouraging results from two phase 2 trials of laru-zova, a gene therapy for X-linked retinitis pigmentosa (XLRP), a rare inherited condition that often leads to blindness. Learn more about the results found: https://brnw.ch/21wWu3f

In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and DAWN patients at month 9 or longer.

10/07/2025

Dr. Albert S. Li is a board-certified ophthalmologist and fellowship-trained retina specialist with a deep commitment to patient care, research, and medical education. A Harvard and NYU graduate, Dr. Li combines clinical excellence with compassionate communication - serving patients across VRCNY in English, Mandarin, Spanish, and Taiwanese. Learn more: https://brnw.ch/21wWqJp

10/02/2025

Not all vision changes are created equal - some may be harmless ocular migraines, while others can signal serious retinal conditions that need urgent care. If you’ve experienced flashes, blind spots, or sudden visual disturbances, it’s important to know when to see a retina specialist. Learn the key differences and when to seek help in our latest blog post: https://brnw.ch/21wWiTN

09/30/2025

“Dr. Ferrone is a good doctor with a great sense of humor. He’s kept my vision going for the past ten years!” 💬 Thank you, Virginia, for your trust and kind words. Long-term care, lasting vision, and a little humor along the way - that’s what we’re all about.

09/28/2025

Today is World Retina Day. It’s a time to raise awareness about vision-threatening conditions such as macular degeneration, diabetic retinopathy and retinal detachment. Preserve your vision to see the 🌎. Book a retina appointment today.

09/25/2025

Dr. Jessica G. Lee is a board-certified retina specialist with advanced training in both adult and pediatric retinal diseases. With a background that spans Cornell, Case Western, and the New York Eye and Ear Infirmary of Mount Sinai, she brings deep expertise in complex retinal conditions, from diabetic retinopathy to pediatric retinal care. Learn more: https://brnw.ch/21wW6rr

09/23/2025

A new study reveals that patients with Parkinson’s disease show significant changes in retinal blood flow and perfusion compared to healthy individuals - suggesting the retina may hold key insights into how PD affects the brain. Learn more: https://brnw.ch/21wW2ao

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.